π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This is a Prospective, Multicenter, Randomized Controlled study to evaluate...
Status
Unknown
Location
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, 430030, Hubei, P. R. China
Start Date
2023-01-01
Trial ID
NCT05583409
Treatments Being Tested
Leptomeningeal metastasis (LM) is a devastating and terminal complication o...
Status
Unknown
Location
Multiple Locations
Start Date
2019-11-01
Trial ID
NCT04148898
Treatments Being Tested
This open-label, multicenter, randomized phase II study will evaluate the u...
Status
Active Not Recruiting
Location
BC Cancer, Vancouver Centre
Start Date
2019-03-19
Trial ID
NCT03769103
Treatments Being Tested
BDTX-1535-101 is an open-label, Phase 1 dose escalation and Phase 2 multipl...
Status
Active Not Recruiting
Location
University of Alabama
Start Date
2022-03-31
Trial ID
NCT05256290
Treatments Being Tested
Aumolertinib is a third-generation epidermal growth factor receptor (EGFR) ...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2022-12-14
Trial ID
NCT05493501
Osimertinib is a third-generation EGFR (Epidermal growth factor receptor) T...
Status
Unknown
Location
Yonsei University Health System, Severance Hospital
Start Date
2021-05-10
Trial ID
NCT04816838
Treatments Being Tested
This is an open-label, multi-centre, single-arm study assessing the efficac...
Status
Active Not Recruiting
Location
Research Site
Start Date
2023-02-09
Trial ID
NCT05546866
Treatments Being Tested
This is a Phase I, open-label, 2-part study in patients with a confirmed di...
Status
Completed
Location
Research Site
Start Date
2014-12-22
Trial ID
NCT02197234
This study will assess the safety and efficacy of Osimertinib with Amivanta...
Status
Active Not Recruiting
Location
Research Site
Start Date
2023-07-18
Trial ID
NCT05801029
Treatments Being Tested
Circulating tumor DNA (ctDNA) is a highly specific and effective biomarker ...
Status
Unknown
Location
Pamela Youde Nethersole Eastern Hospital
Start Date
2017-02-24
Trial ID
NCT02811354
Treatments Being Tested